correspond
author
tel
fax
yjj
tel
fax
ysk
sever
acut
respiratori
syndrom
sar
infecti
diseas
strong
potenti
transmiss
upon
close
person
contact
caus
sarscoronaviru
cov
howev
natur
synthet
compound
current
avail
inhibit
sarscov
examin
inhibitori
effect
purifi
natur
compound
activ
sar
helicas
hepat
c
viru
hcv
helicas
conduct
fluoresc
reson
energi
transfer
fret
base
doublestrand
ds
dna
unwind
assay
use
colorimetrybas
atp
hydrolysi
assay
none
compound
examin
studi
inhibit
dna
unwind
activ
atpas
activ
human
hcv
helicas
protein
found
myricetin
scutellarein
potent
inhibit
sarscov
helicas
protein
vitro
affect
atpas
activ
unwind
activ
addit
observ
myricetin
scutellarein
exhibit
cytotox
normal
breast
epitheli
cell
studi
demonstr
first
time
select
naturallyoccur
flavonoid
includ
myricetin
scultellarein
might
serv
sarscov
chemic
inhibitor
elsevi
ltd
right
reserv
sar
atyp
pneumonia
primarili
transmit
respiratori
droplet
person
contact
sar
epidem
ill
occur
caus
death
around
world
inform
found
http
wwwwhointcsrsarsen
sinc
first
diagnosi
guangdong
provinc
china
success
outbreak
occur
countri
patient
inflict
sar
viru
eventu
develop
symptom
acut
respiratori
distress
syndrom
ard
requir
mechan
ventil
support
surviv
patient
develop
ard
eventu
pass
away
although
mortal
vari
depend
age
addit
rapid
spread
sar
allow
control
clinic
treatment
outbreak
therefor
empir
strategi
employ
treat
patient
agent
antivir
drug
steroid
typei
interferon
howev
retrospect
review
literatur
none
medic
actual
benefit
patient
therefor
need
develop
effect
antisar
viral
agent
event
futur
sar
outbreak
sarscov
isol
shown
class
coronaviru
singl
strand
rna
viru
genom
base
base
genom
sequenc
sarscov
found
moder
relat
human
coronavirus
resembl
three
previous
known
group
coronavirus
coronavirus
member
famili
envelop
virus
replic
cytoplasm
anim
host
cell
upon
infect
target
cell
genom
sarscov
translat
two
larg
replic
polyprotein
subsequ
process
number
nonstructur
protein
nsp
viral
proteas
nsp
includ
rnadepend
rna
polymeras
helicas
sinc
viral
helicas
essenti
viral
genom
replic
current
consid
potenti
target
antivir
drug
develop
present
studi
conduct
identifi
natur
compound
might
inhibit
sarscov
helicas
activ
vitro
order
accomplish
goal
prepar
natur
chemic
stock
tabl
examin
effect
activ
sarscov
helicas
although
sarscov
contain
rnadepend
rna
polymeras
report
possess
dsdna
unwind
activ
well
abil
transloc
along
nucleic
acid
hydrolyz
atp
first
attempt
screen
compound
suppress
dna
unwind
activ
dsdna
unwind
activ
measur
use
fluorometr
assay
base
fret
fluorescein
carboxytetramethylrhodamin
tamra
fig
fret
describ
energi
transfer
mechan
two
dye
molecul
energi
transfer
donor
molecul
acceptor
molecul
approach
highli
use
determin
dynam
interact
two
adjac
molecul
specif
experiment
setup
devis
way
fret
occur
fluorescein
tamra
thu
fluoresc
fluorescein
gener
two
dna
strand
basepair
strong
fluoresc
gener
detect
due
absenc
fret
fluorescein
tamra
duplex
unwound
helicas
base
principl
ad
individu
natur
compound
concentr
lm
dsdnaunwind
reaction
measur
emit
fluoresc
intens
wavelength
nm
experi
none
natur
chemic
inhibit
dsdnaunwind
activ
sar
helicas
fig
ident
experiment
setup
attempt
identifi
chemic
inhibitor
hcv
viral
helicas
found
none
natur
chemic
experi
inhibit
dna
unwind
activ
hcv
viral
helicas
vitro
fig
assess
whether
natur
compound
could
inhibit
atpas
activ
atp
hydrolysi
assay
conduct
presenc
singlestrand
ss
dna
ssdna
base
long
circular
dna
end
therefor
helicas
expect
continu
transloc
along
ssdna
unless
helicas
separ
dna
atp
hydrolysi
assess
use
colorimetr
assay
measur
releas
p
format
molybd
complex
fig
use
experiment
setup
examin
whether
natur
compound
inhibit
atp
hydrolysi
activ
found
natur
chemic
test
myricetin
scutellarein
inhibit
atpas
activ
concentr
figur
abl
detect
compound
natur
compound
librari
suppress
atpas
activ
hcv
viral
helicas
fig
order
determin
ic
valu
fig
suppress
atpas
activ
serial
dilut
measur
inhibitori
effect
atpas
activ
vitro
result
analysi
ic
valu
determin
lm
lm
respect
fig
determin
whether
myricetin
scutellarein
possess
potenti
cytotox
normal
cell
expos
normal
breast
epitheli
cell
myricetin
lm
scutellarein
lm
observ
whether
could
exhibit
inhibitori
effect
growth
cell
result
observ
either
myricetin
scutellarein
affect
growth
cell
cellular
concentr
close
ic
myricetin
scutellarein
fig
suggest
myricetin
scutellarein
safe
compound
pharmacologicallyeffect
concentr
naturallyoccur
chemic
regard
great
sourc
potenti
medic
variou
diseas
particular
gain
great
scientif
interest
due
strong
neuroprotect
cardioprotect
chemoprevent
activ
addit
previou
studi
demonstr
select
naturallyoccur
flavonoid
exhibit
antivir
activ
exampl
administr
silymarin
rich
milk
thistl
significantli
suppress
hepat
b
viru
hbv
relat
hepatocarcinoma
hbv
transgen
mice
quercetin
also
inhibit
hcv
product
hcv
cell
cultur
system
egcg
major
activ
constitu
green
tea
suppress
human
immunodefici
viru
hiv
replic
degrad
semenderiv
enhanc
viru
infect
sevi
requir
hiv
viru
infect
glycyrrhizin
activ
ingredi
liquoric
root
inhibit
sarsassoci
viru
vero
cell
although
clinic
efficaci
sar
viru
patient
requir
verif
present
studi
present
evid
first
time
myricetin
scutellarein
strong
chemic
inhibitor
sarscov
helicas
effect
mediat
inhibit
atpas
activ
inhibit
helicas
activ
hand
myricetin
scutellarein
suppress
helicas
activ
hcv
viru
experi
reason
discrep
current
unknown
may
due
structur
differ
atpas
domain
sarscov
helicas
hcv
helicas
result
also
indic
suppress
sarscov
helicas
myricetin
scutellarein
might
mediat
affect
protein
stabil
andor
integr
sarscov
protein
vitro
sinc
compound
seem
suppress
atpas
activ
hcv
helicas
protein
therefor
would
interest
examin
amino
acid
residu
myricetin
scutellarein
directli
bind
sarscov
helicas
inhibit
atpas
activ
model
analysi
show
myricetin
scutellarein
could
fit
directli
interact
atpadp
bind
pocket
sarscov
helicas
protein
therebi
exclud
direct
bind
atpadp
supplementari
fig
particular
myricetin
like
interfer
atpas
activ
sarscov
helicas
protein
possibl
directli
interact
critic
residu
atpas
domain
supplementari
fig
b
nonetheless
structur
proposit
requir
experiment
verif
futur
collect
propos
myricetin
scutellarein
hold
great
promis
use
treat
control
potenti
futur
sar
outbreak
howev
preclinicalclin
studi
necessari
examin
whether
effect
occur
vivo
treatment
